Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorThomas Jefferson University
About this trial
The objective of the pilot RCT is to evaluate the feasibility and acceptability of a Tai Chi intervention "TaiChi4Joint" vs. an HE AC group for relieving AIIA in women with hormone receptor positive stage I-III BCa. The investigators will pilot test our data collection for mechanism measures via three innovatively integrated biobehavioral pathways.
Eligibility criteria
Qualifiers
Age ≥18 years
Diagnosis of stage I-III hormone receptor-positive breast cancer
Postmenopausal
Currently receiving an aromatase inhibitor (anastrozole, letrozole, or exemestane) or within 5 years of initiation
Disqualifiers
Undergoing active cancer treatment (excluding endocrine therapy)
Uncontrolled cardiac or pulmonary disease that would limit safe participation
Currently engaged in regular structured moderate- or vigorous-intensity exercise (e.g., brisk walking, jogging/running, cycling, swimming, aerobic classes, or resistance training) totaling ≥150 minutes per week over the past 3 months
Currently participating in Tai Chi, yoga, Pilates, or other structured mind-body practice ≥2 times per week over the past 3 months
Trial design
Treatments tested in this trial
- Tai Chi
- Health Education
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov